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CObjectives: The Child Health Utility-9D (CHU-9D) and the Assessment
of Quality of Life-6D (AQOL-6D) presently represent the only two ge-
neric preference-based instruments developed for application with
young people with both adult- and adolescent-specific scoring algo-
rithms. The main objective of this study was to compare and contrast
the application of adult and adolescent scoring algorithms for the
CHU-9D and AQOL-6D in valuing the health of a community-based
sample of adolescents. Methods: A Web-based survey including the
CHU-9D and the AQOL-6Dwas developed for administration to adoles-
cents, aged 11 to 17 years, residing in Australia (n  500). Individual
responses to both instruments were converted to values by using first
the adult and second the adolescent scoring algorithms pertaining to
each instrument. Results: Both the AQOL-6D and the CHU-9D discrim-
nated well according to health status and the presence of long-stand-
ng illness regardless of the scoring algorithm.Within each instrument, O
fectiv
al So
http://dx.doi.org/10.1016/j.jval.2012.04.005owever, important discrepancies were found in that employment of
he adolescent algorithm was found to result in consistently lower
ean health state values for the CHU-9D but consistently highermean
ealth state values for theAQOL-6D relative to the employment of their
espective adult algorithms and these differenceswere statistically sig-
ificant (P 0.05).Conclusion: The differences in adolescent and adult
alues for identical health states are more profound for the CHU-9D
nd ultimately may be significant enough to have an impact on health
are policy. It is important to note that there are important differences
etween the CHU-9D instrument and the AQOL-6D instrument that
ay also have a significant impact on the valuations obtained.
eywords: adolescents, adults, health outcomes, values.
opyright © 2012, International Society for Pharmacoeconomics and
utcomes Research (ISPOR). Published by Elsevier Inc.Introduction
The measurement and valuation of health forms a major com-
ponent of economic evaluation in health care and is a major
issue in health services research. The overall aim of economic
evaluation is to aid decision makers to make efficient and equi-
table decisions about the allocation of scarce resources. Eco-
nomic evaluation seeks to compare the costs and benefits of
health care treatment and preventive programs in a systematic
and transparent manner [1]. There has been an increasing use
of economic evaluation throughout the last decade through the
establishment of regulatory bodies including the National Insti-
tute for Health and Clinical Excellence in England and Wales [2]
nd the Pharmaceutical Benefits Advisory Committee in Austra-
ia [3]. This has resulted in a corresponding increase in the need
or data on the benefits of treatment and preventive programs
or use in economic evaluation. The quality-adjusted life-year
QALY) has become the cornerstone of economic evaluation in
ealth care, with cost-utility analyses (whereby the benefits of
ealth care treatment and preventive programs are typically
* Address correspondence to: Julie Ratcliffe, Flinders Clinical Ef
University, Daws Road, Daw Park, SA 5041, Australia.
E-mail: julie.ratcliffe@flinders.edu.au.
1098-3015/$36.00 – see front matter Copyright © 2012, Internation
Published by Elsevier Inc.represented by QALYs) currently forming the dominant type of
economic evaluation applied in health care both within Austra-
lia and internationally [4]. The most popular mechanism for
calculating QALYs is to employ generic preference-based mea-
sures of health such as the AQOL (Assessment of Quality of Life),
the EuroQol five-dimensional (EuroQol) questionnaire, or the
six-dimensional health state short form (derived from short
from 36 health survey)prospectively, for example, at various
time points during a clinical trial or via some other type of
prospective study design [4]. Generic preference-based instru-
ments comprise two main elements: first, a descriptive system
for measuring health designed for completion by patients (or
members of the general population) comprising a set of multi-
ple attributes with several response categories and second, a
scoring algorithm for valuing health reflecting values for the
health states described by the instrument. For the purposes of
developing the scoring algorithm, the values for a sample of
multiattribute health states are typically derived from an adult
general population sample by using conventional valuation
methods such as standard gamble (SG) or time trade-off (TTO).
eness, A Block Level 1, Repatriation General Hospital, Flinders
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
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731V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 7 3 0 – 7 3 6Statistical modeling methods are then employed to generate
the scoring algorithm with estimation of values for all possible
health states defined by the instrument [4]. Several different
instruments are available including the AQOL, the EuroQol five-
dimensional questionnaire, and the six-dimensional health
state short form (derived from short from 36 health survey).
They have different properties in terms of coverage, sensitivity,
responsiveness, and the methods used to value the health
states, and there is no “gold standard” or general consensus as
to the most appropriate instrument to use [4–6]. In addition,
these instruments were all originally designed for application in
adults and as such their respective scoring algorithms are based
on health state values elicited from adult general population
samples. Despite their adult focus, there are also examples of
these instruments having been applied within cost-utility anal-
yses of adolescent-specific health care treatment and preventa-
tive programs [7].
There is mounting evidence that adult and adolescent values
for identical health states may not correspond and furthermore
that the differences may be significant enough to have an im-
pact on health care policy [8–10]. For example, in a study to
ompare preferences for the health outcomes of neonatal ser-
ices for low-birth-weight babies from three perspectives—
ealth care professionals, parents, and adolescents—Saigal et
l. [11] found that the mean values attached to identical low-
irth-weight–specific health states varied by as much as 0.10 for
arents and adolescents (mean health state value 0.82 for adults
nd 0.72 for adolescents) on the “0” to “1” dead to full health
ALY scale and these differences were statistically significant.
n addition, several other studies, including our own pilot study,
ave found that there are statistically significant differences in
he values attached to identical health states between samples
f adults and young people [12–14].
It is against this background that researchers in health eco-
omics and other disciplines are beginning to recognize the im-
ortance of measuring and valuing health in adolescents from
heir own perspective [15–17]. There are currently three generic
reference-based instruments in the public domain that can be
tilized for economic evaluations of adolescent treatment and ser-
ice programs: the Health Utilities Index Mark 2, the Assessment
f Quality of Life-6D for adolescents (AQOL-6D), and the Child
ealth Utility-9D (CHU-9D). The Health Utilities Index Mark 2 is
he most well-established instrument. It was originally designed
or use in pediatric oncology services, but it has been modified to
ake it suitable for use as a generic instrument [18]. This instru-
ent takes a “within skin” approach to the concept of health in
hat the attributes are symptombased, for example, levels of hear-
ng and vision rather than estimating the impact of the symptoms
n health-related quality of life. Two preference-based scoring al-
orithms are available for calculating health states values for all
ealth states defined by the descriptive system. The first is a mul-
iplicative multiattribute utility function developed by Torrance
nd colleagues [18]. Thismultiattribute utility function is based on
ealth state valuation interviews with 194 parents of school age
hildren inHamilton, Ontario, Canada [18]. The second is a scoring
lgorithm developed by McCabe and colleagues [19] in the UK by
using SG data. The algorithm is based on health state valuation
interviews with 198 members of the UK adult general population.
Currently, there is no adolescent-specific scoring algorithm for the
Health Utilities Index Mark 2.
A child-friendly version of the EuroQol five-dimensional ques-
tionnaire has also been developed by a task force operating across
seven countries on behalf of the EuroQol group. While this instru-
ment can presently be applied in the measurement of health, it
cannot as yet be applied to estimate QALYs within cost-utility
analysis because it does not have a preference-based valuation
algorithm that can be utilized with it [20].The AQOL-6D for adolescents (15–17 year old) is an adaptation
of the existing AQOL-6D utility instrument, which was designed
principally for application in adults (18 years and older) [21–23].
The AQOL-6D is composed of six dimensions (independent living,
mental health, coping, relationships, pain, and senses) and 20
items with four to six response levels, each representing increas-
ing levels of severity [21]. It has a scoring algorithm developed
from application of the TTO technique with a representative sam-
ple of the Australian adult general population [22]. Recently, an
Australian adolescent-specific scoring algorithmhas also been de-
veloped for the AQOL-6D for adolescents from the application of
the TTO technique with students (n  68) in an Australian class-
room setting [23]. An econometric transformation of the TTO
scores derived from a selection of directly valued AQOL-6D health
states was carried out by regressing the TTO scores on predicted
scores from the AQOL-6D to produce an adolescent-specific algo-
rithm that incorporates adolescent-specific “corrections” to the
Australian adult utility weights [23]. Utility algorithms for both the
AQOL-6D and its adolescent version were revised in 2012 (http://
www.aqol.com.au/).
The CHU-9D is a new generic preference-based instrument de-
signed for economic evaluations of health care treatment and pre-
ventive programs for children and adolescents. Unlike other in-
struments that are modified versions of measures originally
designed for use with adults, the CHU-9D was developed from its
inception for use with young people [24,25]. The CHU-9D com-
prises nine attributes (worried, sad, pain, tired, annoyed, school-
work, sleep, daily routine, and ability to join in activities) with five
different levels representing increasing levels of severity within
each attribute. The CHU-9D descriptive system was developed
from in-depth qualitative interviewswith young people to identify
the attributes of health most relevant to this population [24].
While it was originally developed for use with younger children
aged 7 to 11 years, the instrument is increasingly being applied
with adolescents in the 11- to 17-year age group. A number of
studies have demonstrated the practicality and face and construct
validity of the CHU-9D in the Australian adolescent general popu-
lation [17,26–28]. The CHU-9D has demonstrated good practicality
and validity in psychometric testing undertaken in general UK
primary school and Australian primary and secondary school
samples and in clinical populations [17,25,29]. The instrument is
currently being applied internationally in a number of research
programs focused on the adolescent age group including new in-
novative treatment programs for type 1 diabetes, attention deficit/
hyperactivity disorder, mental health, obesity prevention, and
liver transplantation.
While the CHU-9D descriptive systemwas developedwith young
people, the original scoring algorithm for the CHU-9D was based on
adult general population values using the SG method [30]. We have
recently developed an adolescent-specific scoring algorithm for the
CHU-9D, however, by applying best-worst scaling discrete choice ex-
periment (DCE) methods to value CHU-9D health states with an ad-
olescent general population sample (n 590) aged 11 to 17 years. Full
details on the development of the adolescent-specific scoring algo-
rithm for the CHU-9D are reported elsewhere [14].
The main objective of this study was to apply the CHU-9D and
the AQOL-6D simultaneously tomeasure and value the health of a
community-based sample of adolescents.We chose to apply these
two instruments because these currently represent the only two
generic preference- based instruments developed for application
with young people with both adult- and adolescent-specific scor-
ing algorithms. Specifically, we sought to assess, by empirical
comparison, the comparability (or otherwise) of the health state
values generated from the application of the respective adult- and
adolescent-specific scoring algorithms. Comparability was as-
sessed at both an aggregate level and disaggregating according to
self-reported health status and key socioeconomic characteristics.
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AWeb-based surveywas developed for administration to a commu-
nity-based sample of adolescents aged 11 to 17 years residing inAus-
tralia. The survey was administered in collaboration with an inde-
pendentmarket research company that has an existing online panel
of parents who have given approval for their adolescent children to
participate in research studies and have provided prior information
on their adolescent’s home address, age, and sex. Both parent and
adolescent dyad consent was obtained prior to participation in the
present survey. Once consent from both parties was obtained, the
adolescent completed a survey that contained three main sections.
Section A comprised the CHU-9D instrument. Section B comprised
the AQOL-6D instrument. Section C included a self-reported general
health question with five response options (excellent, very good,
good, fair, and poor); a question relating to whether the participant
had a long-standing disability, illness, or medical condition; and a
series of sociodemographic questions including age, sex, and socio-
economic status as measured by the Family Affluence Scale (FAS), a
validated measure of socioeconomic position that is designed for
self-report by adolescents aged 11 to 17 years [31]. The instrument
includes four items relating to family affluence: (1) “Does your family
own a car, van or truck?” (no/yes one/yes two or more); 2) “Do you
haveyourownbedroomfor yourself?” (no/yes); 3) “During thepast 12
months how many times did you travel away on holiday (vacation)
with your family?” (not at all/once/twice/more than twice); and 4)
“Howmany computers does your family own?” (none/one/two/more
than two). The score is calculated on a 0- to 7-point scale, with 1
point each for having one car, one computer, and one room and
one extra point each for having more than one car, holiday, or
computer. A lower score represents a lower level of affluence
and vice versa [31]. Participants were grouped into three cate-
Table 1 – Characteristics of the sample (N = 500).
Age (y), mean  SD 15  1.7
Females, n (%) 253 (51)
Self-reported general health, n (%)
Excellent 181 (36)
Very good 184 (37)
Good 97 (19)
Fair 30 (6)
Poor 8 (2)
Long-standing illness or disability
Yes 80 (16)
No 420 (84)
Family affluence
Low (FAS score  3) 51 (11)
Medium (FAS score  4 or 5) 203 (41)
High (FAS score  6) 246 (49)
FAS, Family Affluence Scale.
Table 2 – CHU-9D and AQOL-6D values by scoring algorithm
Instrument Adolescent: mean value  SD
Median value (25th–75th
percentiles)
Adult: m
Median
p
CHU-9D 0.782  0.160 0
0.809 (0.653–0.909) 0.84
AQOL-6D 0.784  0.225 0
0.875 (0.683–0.960) 0.82
AQOL-6D, Assessment of Quality of Life-6D; CHU-9D, Child Health Ut
* Difference between means is highly statistically significant (P  0.001).gories on the basis of their FAS score—those with scores less
than or equal to 3, those with FAS scores of 4 or 5, and those with
FAS scores of greater than or equal to 6.
The individual responses to the nine CHU-9D questions were
initially converted to health state values (on the 0–1 dead to per-
fect health QALY scale) by using the existing UK adult general
population algorithm developed by Stevens [30]. The CHU-9D re-
sponses were also converted to adolescent-specific health state
values by using the new adolescent-specific scoring algorithm de-
veloped by Ratcliffe et al. [14]. Similarly, the individual responses
to the 20 AQOL-6D questions were initially converted to health
state values by using the updated 2012 Australian adult general
population algorithm originally developed by Richardson et al.
[22]. The AQOL-6D responses were also converted to adolescent-
specific health state values by using the new updated 2012 adoles-
cent-specific scoring algorithm originally developed by Moodie et
al. [23]. Both updated algorithms can be accessed via the AQOL
Web site (http://www.aqol.com.au/).
All statistical analyses were performed by using SPSS version
19.0 [32]. For both the CHU-9D and the AQOL-6D, the health state
values derived from the application of the adult scoring algorithm
were compared with the health state values derived from the ap-
plication of the adolescent scoring algorithm by using basic
descriptive statistics including means, medians, and ranges. Nor-
mality was tested for all data by employing the Kolmogorov-Smir-
nov test. The relationship between values was also explored
graphically by comparing the values derived from the application
of each scoring algorithm by using a scatter plot. Adolescent-spe-
cific and adult health state values were also compared at a disag-
gregated level according to the adolescents’ overall rating of their
general health and between those who reported themselves as
living with a long-standing disability, illness, or medical condition
or not. The relationship between adult and adolescent values for a
number of sociodemographic variables (gender, sex, and socioeco-
nomic status as classified by the FAS) was also investigated. The
difference between groups was assessed by employing the
Kruskal-Wallis one-way analysis of variance and pairwise com-
parison (Mann-Whitney U) test.
Results
A total of 699 adolescents were approached to participate in the
survey of whom 142 declined to participate and 57 provided in-
complete responses, giving a useable response rate of 72% (500 of
699). Table 1 summarizes the characteristics of the respondents.
Themean age of respondentswas 15 1.7 years,with n 253 (51%)
being females. As expected for a community-based sample, the
vast majority of respondents reported themselves in excellent or
very good health (n  365, 73%), with only a small proportion re-
porting themselves in fair or poor health (n  32, 8%). Table 2
ummarizes CHU-9D and AQOL-6D values differentiated accord-
ng to the employment of the adolescent-specific and adult scoring
olescent versus adult.
value  SD
e (25th–75th
ntiles)
Difference between
means
95% confidence
interval
0.123 0.051* 0.067 to 0.034
62–0.907)
0.234 0.041* 0.039–0.042
19–0.933)
9D.: ad
ean
valu
erce
.833 
9 (0.7
.743 
5 (0.6
ility-
t
c
r
s
C
t
c
e
a
o
a
c
c
t
c
t
f
h
d
(
w
t
W
a
a
(
a
w
B
g
0
1
t
a
A
l
p
o
h
t
B
o
t
t
e
f
s
733V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 7 3 0 – 7 3 6algorithms pertaining to each instrument. For both instruments,
the employment of the adolescent algorithms results in lower
mean health state values than the adult algorithm and these dif-
ferences are statistically significant (P  0.05). It is also important
to note that the difference between mean adolescent and adult
values is noticeably higher for the CHU-9D than for the AQOL-6D.
Figure 1 shows a scatter diagram of the relationship between
adult and adolescent values for the CHU-9D. It can be seen that
adult values are higher than the corresponding adolescent values
for the vast majority (84%) of health state classifications reported
by the respondents. Figure 2 shows a scatter diagram of the rela-
ionship between adult and adolescent values for the AQOL-6D. In
ontrast to the CHU-9D, the AQOL-6D demonstrates a converse
elationship; the adolescent values are higher than the corre-
ponding adult values. In addition, and again in contrast to the
HU-9D, the difference between adolescent and adult values for
he AQOL-6D is systematic. This finding is reflective of the adoles-
ent scoring algorithm for the AQOL-6D, which employs a uniform
conometric transformation of the adult disutility values (with
dult disutility values raised to the power of 1.19) to generate ad-
lescent-specific values [23].
Table 3 summarizes CHU-9D and AQOL-6D values differenti-
ted by sociodemographic characteristics according to the appli-
ation of the adolescent-specific and adult scoring algorithms. It
an be seen that although the directions of the relationships be-
ween the employment of adult or adolescent algorithms and so-
iodemographic variables were very similar for each instrument,
he mean adolescent values were, on average, consistently lower
or all the examined relationships for the CHU-9D but consistently
igher for the AQOL-6D in comparisonwith adult values and these
ifferences were highly statistically significant in all instances
Mann-Whitney U test, P  0.001). For both instruments, there
ere statistically significant (within-algorithm) differences be-
ween mean values differentiated according to age group (Mann-
hitney U test, P  .05) and levels of family affluence (one-way
nalysis of variance, P  .05), but the differences in mean values
ccording to sex were statistically significant only for the CHU-9D
Mann-Whitney U test, P  0.05).
Table 4 summarizes CHU-9D and AQOL-6D values differenti-
ted by self-reported general health and the presence (or other-
ise) of a long-standing illness, disability, or medical condition.
oth instruments discriminated well according to self-reported
eneral health, with themean values ranging from amaximum of
Fig. 1 – Scatter plot comparison of adult and adolescent
values for the Child Health Utility-9D..913 for those who reported themselves in excellent health (n 81, AQOL-6D adolescent value) versus a minimum of 0.343 for
hose who reported themselves in poor health (n  38, AQOL-6D
dult value), the range of mean values being larger for the
QOL-6D than for the CHU-9D. When comparing adult and ado-
escent values within self-reported health categories, a similar
attern can be observed in that the mean adolescent values were,
n average, consistently lower for the CHU-9D but consistently
igher for the AQOL-6D and these differences were highly statis-
ically significant in all instances (Mann-WhitneyU test, P 0.001).
oth instruments discriminatedwell according to the presence (or
therwise) of a long-standing illness, disability, or medical condi-
ion. However, again similar differences were observed between
he instruments in that the mean adolescent values were, on av-
rage, consistently lower for the CHU-9D but consistently higher
or the AQOL-6D and these differences were highly statistically
ignificant in all instances (Mann-Whitney U test, P  0.001).
Discussion
To our knowledge this is the first study internationally to empiri-
cally compare the application of adolescent-specific and adult
health state values for the CHU-9D and the AQOL-6D. These two
instruments are unique in that they currently represent the only
two generic preference-based instruments (designed for incorpo-
ration into the economic evaluation of adolescent-specific health
care treatment and preventive programs) that have developed ad-
olescent-specific scoring algorithms. The development of adoles-
cent-specific scoring algorithms for both the CHU-9D instrument
and the AQOL-6D instrument represents an important method-
ological milestone for economic evaluation in health care and
public health sectors by offering the potential for the systematic
incorporation of adolescent views into the economic evaluation of
treatment and preventive programs designed for this age group.
Although the directions of the observed relationships between
several sociodemographic and general health variables were gen-
erally the same regardless of whether the adult or adolescent al-
gorithms for the CHU-9D and the AQOL-6D were employed, the
mean adolescent values were, on average, consistently lower for
the CHU-9D and consistently higher for the AQOL-6D for all the
examined relationships and in every case these differences were
highly statistically significant.
For the CHU-9D instrument, the implications of the direction of
the differences between adult and adolescent values for identical
health states and the magnitude of those differences for the eco-
Fig. 2 – Scatter plot comparison of adult and adolescent
values for the Assessment of Quality of Life-6D.
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734 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 7 3 0 – 7 3 6nomic evaluation of adolescent-specific health care treatment and
preventive programs designed for this age group could be signifi-
cant. For example, in the case of a (hypothetical) new health care
treatment targeted at adolescents that moves adolescents from
“fair” general health to “excellent” general health, the incremental
QALY gain as measured and valued by the CHU-9D is 0.257 (mean
health state value: 0.602 fair health, 0.859 excellent health) on the
0 to 1 QALY scale when the adolescent scoring algorithm is em-
ployed and 0.215 (mean health state value: 0.676 fair health, 0.891
excellent health) when the adult scoring algorithm is employed.
For a new adolescent health care treatment program costing an
additional $ 12,000 per patient, the incremental cost per QALY
gained is $ 12,000/0.257  $ 46,692 using the adolescent value and
$ 12,000/0.215  $ 55,813 using the adult value, representing an
overall reduction of 20% in total estimated cost-effectiveness. The
magnitude of this difference would also be much larger if a longer
lifetime perspective were adopted. Although no explicit threshold
value exists in Australia for determining the cost-effectiveness of
new pharmaceuticals and health care technologies, the Pharma-
ceutical Benefits Advisory Committee considers interventions
with cost per QALY ratios above $50,000 to be high and the prob-
ability of reimbursement is reduced accordingly [33]. Therefore,
for the CHU-9D, the difference between adult and adolescent
health state values could be significant enough tomake the differ-
ence between adoption and nonadoption of a new intervention for
this age group. In contrast, replicating the same exercise for the
AQOL-6D indicates little disagreement in values, generating very
similar incremental cost per QALY gains of $ 12,000/0.520  $
3,076 using the adolescent value and $ 12,000/0.540  $ 22,222
sing the adult value.
The reasons for these differences between the instruments are
nclear but are potentially attributable to several factors including
ifferences in the descriptive systems for each instrument, the
ature of the samples utilized for valuation, and the valuation
ethods used to develop the respective scoring algorithms. The
QOL-6D and CHU-9D descriptive systems are quite different,
ith some dimensions included in the AQOL-6D being excluded
rom the CHU-9D and vice versa. In addition, the CHU-9D has a
elatively higher proportion overall of dimensions related to men-
al health than does the AQOL-6D (4 of 9 dimensions for the
HU-9D vs 4 of 20 items for the AQOL-6D). The adolescent algo-
ithm for the AQOL-6D is based on the TTO elicitation technique
pplied in a classroom setting with a relatively small sample of
dolescents. It also represents a uniform econometric transforma-
ion of the adult values for the same instrument. In contrast, the
dult algorithm for the CHU-9D is based on the SG method, while
he adolescent algorithm has been developed by applying best-
orst scaling DCE methods with a relatively large sample of ado-
escents in a community home-based setting.
It is also important to note that to use the adolescent health
tate values for the CHU-9D generated from the best-worst scaling
CE approach within cost-effectiveness, they must be rescaled to
he full health-death state required for the estimation of QALYs.
or the CHU-9D adolescent scoring algorithm, the existing adult
eneral population value for the most severe or PITS health state
rom the existing adult general population scoring algorithm was
sed to reanchor the estimates to ensure that zero represented
eath rather than the utility of the most severe health state. The
eliance on the existing adult general population value for the
ost severe or PITS health state for rescaling may be viewed as a
imitation andwe are unable to rule out the possibility that at least
ome of the variation we have observed between adolescent and
dult values for the CHU-9D could be attributable to thismethod of
escaling. Recent research by Brazier and colleagues [34] has high-
ighted that mapping from a small sample of health states valued
sing the conventional TTO approach offers a superior method ofrescaling than the anchoringmethod. Further research is planned
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735V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 7 3 0 – 7 3 6to investigate this possibility for the CHU-9Dwith an older adoles-
cent population (16- and 17-year-olds), with the aim of generating
adolescent-specific health state values for a small sample of
CHU-9D health states for the purposes of rescaling the best-worst
estimates. It would also be preferable for further research to re-
move the possibility of ordering effects in responses to each in-
strument by utilizing a random ordering for the presentation of
the instruments for completion by respondents.
The question of whose values are used in cost-effectiveness
analysis ultimately reflects a normative decision [4]. Historically,
the estimation of QALYs gained within the framework of cost-
effectiveness analysis for adolescent-specific treatment and pre-
ventive programs has tended to incorporate the views of adults as
themain source of preferences. This approach is consistent with a
public policy perspective for decision making in relation to the
allocation of scarce health care resources whereby only the pref-
erences of members of the general population who are eligible to
vote according to constitutional law (adults older than 18 years)
and who contribute toward financing the health care system
through general taxation are taken into account and the prefer-
ences of other population groups including adolescents are there-
fore excluded [35]. It may also be argued, however, that the incor-
poration of the preferences of adolescents into cost-effectiveness
analyses of treatment and service programs designed for this age
group has the potential to facilitate the development of treatment
and service programs that are more relevant to the needs of ado-
lescents,more likely to produce positive outcomes for adolescents
seeking help from health care services, andmore likely to produce
positive outcomes for adolescents with health problems [14]. This
argument may be particularly pertinent for the application of the
CHU-9D in the context of the economic evaluation of adolescent
mental health services because the newly developed adolescent
scoring algorithm indicates that adolescents place significantly
more weight on mental health impairment states than do adults.
The mean values attached to identical mental health impairment
states vary by 0.12 on the 0 to 1 QALY scale (mean health state
value 0.87 for adults and 0.75 for adolescents) [14]. This difference
would likely have a significant impact on any assessment of
the cost-effectiveness of a new mental health treatment or pre-
ventive program. Furthermore, the reliance on adult health state
values for the cost-effectiveness analysis of treatment and pre-
ventive programs targeted at adolescents also contributes to the
more general sense of exclusion of adolescent views fromdecision
making in relation to their health and health care, an important
known contributor to poor treatment adherence in this age
group [15].
In summary, the findings from this study indicate the possibil-
ity of a bias in adult health state values relative to those elicited
from adolescents. The results, however, should be interpreted
with caution. It is possible that the differences we have observed
between the AQOL-6D and the CHU-9D are an artifact due to the
different valuation methods used in the development of each
scoring algorithm (AQOL-6D adults and adolescents: TTO; CHU-9D
adolescents: best-worst scaling DCE; adults: SG). A study is cur-
rently underway to replicate the best-worst scaling DCE CHU-9D
valuation exercise with an Australian adult population that will
inform this issue for the CHU-9D by demonstrating to what extent
adults and adolescents have the same relative preferences for all
CHU-9D health states controlling for the valuationmethod. If such
similarity is demonstrated, then it is likely that the differences
observed between adults and adolescents may be explained by
age-related differences in the length of life and quality-of-life
trade-off rather than the weights attached to specific dimensions
or groups of dimensions (e.g., physical vs. mental health). These
findings concur with an expanding evidence base highlighting ap-
parent discrepancies in adult and adolescent values for identical
health states [36–38]. The differences between adolescent and
T C G P L P A * † ‡
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736 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 7 3 0 – 7 3 6adult values are more profound for the CHU-9D and ultimately
may be significant enough to have an impact on health care policy.
However, it is important to note that this study has also high-
lighted important potential differences between the CHU-9D in-
strument and the AQOL-6D instrument that may also have a sig-
nificant impact on the valuations obtained. Further research of
both a methodological and empirical nature is required to further
elucidate and substantiate these findings in both clinical adoles-
cent and other adolescent general population samples.
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